GreenLight Biosciences Holdings, PBC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GreenLight Biosciences Holdings, PBC quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q4 2022.
  • GreenLight Biosciences Holdings, PBC Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $131M, a 76.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $131M +$57M +76.6% Dec 31, 2022 10-K 2023-03-28
Q4 2021 $74.3M Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.